Cargando…
Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?
SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the sixth most frequently diagnosed cancer in men and the tenth in women with a rising incidence. The treatment of metastasized RCC has dramatically changed in the last decade, improving the overall survival of patients significantly. In this context, co...
Autores principales: | Michaelis, Jakob, Grabbert, Markus, Sigle, August, Yilmaz, Mehmet, Schlager, Daniel, Gratzke, Christian, Miernik, Arkadiusz, Schoeb, Dominik Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367545/ https://www.ncbi.nlm.nih.gov/pubmed/35954446 http://dx.doi.org/10.3390/cancers14153777 |
Ejemplares similares
-
Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?
por: Sigle, August, et al.
Publicado: (2021) -
Individualized Decision Making in Transperineal Prostate Biopsy: Should All Men Undergo an Additional Systematic Biopsy?
por: Sigle, August, et al.
Publicado: (2022) -
Experimental ex-vivo performance study comparing a novel, pulsed thulium solid-state laser, chopped thulium fibre laser, low and high-power holmium:YAG laser for endoscopic enucleation of the prostate
por: Yilmaz, Mehmet, et al.
Publicado: (2021) -
Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up
por: Kohl, Tobias, et al.
Publicado: (2021) -
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
por: Suarez-Ibarrola, Rodrigo, et al.
Publicado: (2020)